Dehydrated alcohol - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dehydrated alcohol and what is the scope of freedom to operate?
Dehydrated alcohol
is the generic ingredient in two branded drugs marketed by Bpi Labs, Accord Hlthcare, Breckenridge, Ingenus Pharms Llc, Xgen Pharms, and Be Pharms, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.Nine suppliers are listed for this compound.
Summary for dehydrated alcohol
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Master File Entries: | 1 |
| Finished Product Suppliers / Packagers: | 9 |
| Clinical Trials: | 9 |
| What excipients (inactive ingredients) are in dehydrated alcohol? | dehydrated alcohol excipients list |
| DailyMed Link: | dehydrated alcohol at DailyMed |
Recent Clinical Trials for dehydrated alcohol
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ablative Solutions, Inc. | PHASE3 |
| Icahn School of Medicine at Mount Sinai | PHASE1 |
| Mode Sensors AS | N/A |
US Patents and Regulatory Information for dehydrated alcohol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bpi Labs | ABLYSINOL | dehydrated alcohol | SOLUTION;INTRA-ARTERIAL | 207987-002 | Jun 21, 2018 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Breckenridge | DEHYDRATED ALCOHOL | dehydrated alcohol | SOLUTION;INTRA-ARTERIAL | 219444-001 | Jun 23, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Accord Hlthcare | DEHYDRATED ALCOHOL | dehydrated alcohol | SOLUTION;INTRA-ARTERIAL | 217845-001 | Jun 23, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Xgen Pharms | DEHYDRATED ALCOHOL | dehydrated alcohol | SOLUTION;INTRA-ARTERIAL | 219400-001 | Jun 23, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
